Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1995-11-03
1999-11-02
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514212, 5142335, 514320, 514324, 514422, 514469, 540596, 544153, 546202, 548525, 549 49, A61K 3156, A61K 31445, C07D40912
Patent
active
059770937
ABSTRACT:
A method for alleviating the symptoms of post-menopausal syndrome comprising administering to a woman in need thereof an effective amount of a compound of formula I wherein
REFERENCES:
patent: 3293263 (1966-12-01), Lednicer
patent: 3320271 (1967-05-01), Lednicer
patent: 3394125 (1968-07-01), Crenshaw
patent: 3413305 (1968-11-01), Crenshaw
patent: 3862232 (1975-01-01), Lednicer
patent: 4117128 (1978-09-01), Brenner
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4418068 (1983-11-01), Jones
patent: 4910212 (1990-03-01), Boyle et al.
patent: 5013761 (1991-05-01), Beedle et al.
patent: 5223510 (1993-06-01), Gubin et al.
patent: 5254568 (1993-10-01), Kapil et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5488058 (1996-01-01), Palkowitz
patent: 5492922 (1996-02-01), Palkowitz
patent: 5510357 (1996-04-01), Palkowitz
patent: 5510498 (1996-04-01), Palkowitz
Sitruk-Ware, R. "Menopause which progestin to use . . . " BA 85:051565, 1987.
Robison et al., "Reveral of the antitumor effects of tamoxifen by progesterone . . . " BA 85:006817, 1987.
Jeng et al. "Estrogenic potention of ptogestins . . . " Can. Res. v.52, p. 6537-46, 1992.
Christman et al. "Chemotherapy of metastatic breast cancer in the elderly . . . " AMA abstract, 1992.
Need et al. "Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women" index Medicus 87:01037, 1987.
Crenshaw, R. R., et al., J. Med. Chem., 14(12) :1185-1190 (1971).
Durani, N., et al., Indian J. Chem., 22B:489-490 (1983).
Jones, C. D., et al., J. Med. Chem., 35:931-938 (1992).
Lednicer, D., et al., J. Med. Chem., 8:52-57 (1964).
Madesclaire, M., Tetrahedren, 42 (20); 5459-5495 (1986).
Trost, B.M., et al., Tetrahedren Letters, 22 (14) ; 1287-1290, (1981).
Drabowicz, J., et al., Synthetic Communications, 11 (12); 1025-1030 (1981).
Kramer, J.B., et al. 34th National Organic Symposium, Williamsburg, VA, (Jun. 11-15, 1995).
Wyngaarden, et al., Cecil Textbook of Medicine, 16: 1271 (1983).
Boudreaux William R.
Chang Ceila
Eli Lilly and Company
LandOfFree
Benzothiophene compounds, intermediates, compositions, and metho does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiophene compounds, intermediates, compositions, and metho, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiophene compounds, intermediates, compositions, and metho will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135622